Literature DB >> 6548697

Reversible diminished calcitonin secretion in the rat during chronic hypercalcemia.

F Raue, I Deutschle, C Küntzel, R Ziegler.   

Abstract

A transient increase in serum calcitonin (CT) concentration is induced by an acute iv calcium (Ca) load, whereas in the chronic hypercalcemic state, serum CT levels, as well as CT content of the thyroid, are equivocal. The secretion of CT was tested in three models of hypercalcemia in rats: tumor induced by the hypercalcemic Walker carcinosarcoma 256 (HWCS 256), chronic parenteral Ca administration, and chronic 1,25(OH)2D3 administration. In rats with HWCS 256, serum CT levels increased from basal values of 0.21 +/- 0.11 ng/ml to a maximum of 0.42 +/- 0.20 ng/ml on day 4 after tumor transplantation, 1 day before serum Ca increased. The serum CT levels declined again the following day (day 5). In thyroidectomized, parathyroid autotransplated rats with HWCS 256, serum Ca increased 1 day earlier than in intact rats. Substitution of CT by exogenous CT injections delayed the hypercalcemia for one day. Ca loading was followed by a decreased serum CT level (delta CT); the CT content of the thyroid fell from 9.4 +/- 1.1 ng/mg wet wt to 1.0 +/- 0.3 ng/mg wet wt. While hypercalcemia was present. Also chronic intraperitoneal Ca administration induced a decrease in the CT response to a Ca load (delta CT) and a decrease in thyroid CT content from 9.32 +/- 0.58 ng/mg wet wt to 3.84 +/- 0.33 ng/mg wet wt. These changes were no longer present 4 days after stopping Ca administration. In chronic hypercalcemia induced by 1,25(OH)2D3 administration, basal serum CT levels did not vary significantly, whereas serum Ca increased to 11.8 +/- 0.46 mg/dl on day 4. CT after an acute Ca load was diminished, as was CT content of the thyroid during 1,25(OH)2D3 administration. These changes were reversible after stopping 1,25(OH)2D3 administration. During chronic hypercalcemia a reversible exhaustion of CT content of the thyroid and a diminished CT response to acute Ca stimulation was observed, while basal serum CT levels remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548697     DOI: 10.1210/endo-115-6-2362

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Chronic hypervitaminosis D3 determines a decrease in C-cell numbers and calcitonin levels in rats.

Authors:  I Martín-Lacave; F Ramos; J C Utrilla; E Conde; A Hevia; R Fernández; A M Moreno; J M Fernández-Santos; H Galera-Davidson
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

2.  Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.

Authors:  M Gunness-Hey; J M Hock; I Gera; J Fonseca; J Poser; J Bevan; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-04       Impact factor: 4.333

3.  Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.

Authors:  T Naveh-Many; J Silver
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Stimulation of calcitonin secretion by calcium receptor activators: evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin.

Authors:  J R Lavigne; R J Zahradnik; R L Conklin; L D Lambert; M A Logan; A Parihar; J Fox
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

5.  Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Authors:  Arnold J Felsenfeld; Barton S Levine
Journal:  Clin Kidney J       Date:  2015-03-20

6.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.